House Republicans on the Energy and Commerce Committee got a win over House Speaker Nancy Pelosi (D-CA) on Wednesday, defeating HR 3, the speaker’s “radical price control scheme” for prescription drugs.
?? BREAKING ??
— Energy & Commerce GOP (@HouseCommerce) September 15, 2021
Speaker Pelosi’s socialist drug price controls FAILS to pass in @HouseCommerce by bipartisan vote.
This is a huge win for MORE CURES and people who deserve a fighting chance at life.
Three Democrats also joined Republicans in voting down the measure.
BIG: Energy & Commerce fails to adopt prescription drug negotiating policy. 29-29
— Jake Sherman (@JakeSherman) September 15, 2021
3 Ds — Rice, Peters and Schrader — vote no.
Pelosi spox says it’s still "a cornerstone of the Build Back Better Act as work continues between the House, Senate and White House on the final bill.” https://t.co/eRNE1Rzz2S
Congresswoman Cathy McMorris Rodgers (R-WA), ranking member on the committee, argued that the now-defeated proposal would “ lead to less innovation, fewer cures, and no hope for many people who deserve a fighting chance at life.”
Recommended
“Whether it’s ALS, Alzheimer’s, Huntington’s, Spinal Muscular Atrophy or another diseases, the hope for lifesaving treatments and cures is here in America. We must not forget that it is here that hope becomes a reality," she said in a statement following the committee vote. “America will not win the future, if Speaker Pelosi’s socialist price controls were jammed in the Democrat’s reckless tax and spending spree. It would lead to less innovation, fewer cures, and no hope for many people who deserve a fighting chance at life.”
Join the conversation as a VIP Member